# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-19-000199
Filing Date
2019-11-08
Accepted
2019-11-08 16:05:45
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20190930.htm iXBRL | 10-Q | 2102984
2 | EX-31.1 | lgnd93019exhibit311.htm | EX-31.1 | 20761
3 | EX-31.2 | lgnd93019exhibit312.htm | EX-31.2 | 21091
4 | EX-32.1 | lgnd93019exhibit321.htm | EX-32.1 | 15175
10 |  | lgnd-20190930_g1.jpg | GRAPHIC | 11735
| Complete submission text file | 0000886163-19-000199.txt |  | 8620153

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20190930.xsd | EX-101.SCH | 41182
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20190930_cal.xml | EX-101.CAL | 109325
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20190930_def.xml | EX-101.DEF | 252488
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20190930_lab.xml | EX-101.LAB | 637558
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20190930_pre.xml | EX-101.PRE | 401329
19 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20190930_htm.xml | XML | 1690800

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 191204072
SIC: 2834 Pharmaceutical Preparations